Mannatech Inc (MTEX) stock
MTEXNasdaqMedicinal Chemicals & Botanical ProductsFiscal year ends December 31
$2.83−0.93 (-24.73%)
Close on Nov 17, 2026Market cap $5.46MP/E –Yield –
Mannatech operating income
Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.
Mannatech's operating income for the twelve months ending Jun 30, 2026 was $2.67M. For fiscal 2025 it was -$426.00K, down 129.8% from the year before. The highest annual figure on record is $12.74M in fiscal 2014.
Annual operating income
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$426.00K | -129.8% |
| FY2024 | Dec 31, 2024 | $1.43M | – |
| FY2023 | Dec 31, 2023 | -$964.00K | – |
| FY2022 | Dec 31, 2022 | -$405.00K | -104.5% |
| FY2021 | Dec 31, 2021 | $9.05M | +101.5% |
| FY2020 | Dec 31, 2020 | $4.49M | -30.2% |
| FY2019 | Dec 31, 2019 | $6.43M | – |
| FY2018 | Dec 31, 2018 | -$90.00K | -103.6% |
| FY2017 | Dec 31, 2017 | $2.52M | +281.1% |
| FY2016 | Dec 31, 2016 | $661.00K | -94.6% |
| FY2015 | Dec 31, 2015 | $12.14M | -4.7% |
| FY2014 | Dec 31, 2014 | $12.74M | +167.9% |
| FY2013 | Dec 31, 2013 | $4.76M | – |
| FY2012 | Dec 31, 2012 | -$980.00K | – |
| FY2011 | Dec 31, 2011 | -$16.89M | – |
| FY2010 | Dec 31, 2010 | -$11.48M | – |
| FY2009 | Dec 31, 2009 | -$25.59M | – |
| FY2008 | Dec 31, 2008 | -$14.50M | -290.6% |
| FY2007 | Dec 31, 2007 | $7.61M | – |
Quarterly operating income
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $998.00K | – |
| Q1 FY2026 | Mar 31, 2026 | -$180.00K | – |
| Q4 FY2025 | Dec 31, 2025 | -$157.00K | -118.2% |
| Q3 FY2025 | Sep 30, 2025 | $2.01M | +126.3% |
| Q2 FY2025 | Jun 30, 2025 | -$1.44M | – |
| Q1 FY2025 | Mar 31, 2025 | -$833.00K | -201.6% |
| Q4 FY2024 | Dec 31, 2024 | $864.00K | – |
| Q3 FY2024 | Sep 30, 2024 | $887.00K | +415.7% |
| Q2 FY2024 | Jun 30, 2024 | -$1.14M | – |
| Q1 FY2024 | Mar 31, 2024 | $820.00K | +15.0% |
| Q4 FY2023 | Dec 31, 2023 | -$895.00K | – |
| Q3 FY2023 | Sep 30, 2023 | $172.00K | -87.3% |
| Q2 FY2023 | Jun 30, 2023 | -$954.00K | -211.8% |
| Q1 FY2023 | Mar 31, 2023 | $713.00K | +1937.1% |
| Q4 FY2022 | Dec 31, 2022 | -$2.65M | -231.3% |
| Q3 FY2022 | Sep 30, 2022 | $1.36M | -51.3% |
| Q2 FY2022 | Jun 30, 2022 | $853.00K | – |
| Q1 FY2022 | Mar 31, 2022 | $35.00K | -97.5% |
| Q2 FY2021 | Jun 30, 2021 | $2.02M | +81.8% |
| Q1 FY2021 | Mar 31, 2021 | $2.79M | +38.7% |
| Q4 FY2020 | Dec 31, 2020 | -$11.00K | -100.4% |
| Q3 FY2020 | Sep 30, 2020 | $1.38M | +144.2% |
| Q2 FY2020 | Jun 30, 2020 | $1.11M | -45.0% |
| Q1 FY2020 | Mar 31, 2020 | $2.01M | +79.6% |
| Q4 FY2019 | Dec 31, 2019 | $2.73M | – |
| Q3 FY2019 | Sep 30, 2019 | $565.00K | -66.2% |
| Q2 FY2019 | Jun 30, 2019 | $2.02M | – |
| Q1 FY2019 | Mar 31, 2019 | $1.12M | – |
| Q4 FY2018 | Dec 31, 2018 | -$524.00K | -149.9% |
| Q3 FY2018 | Sep 30, 2018 | $1.67M | +144.2% |
| Q2 FY2018 | Jun 30, 2018 | -$349.00K | -112.4% |
| Q1 FY2018 | Mar 31, 2018 | -$888.00K | – |
| Q4 FY2017 | Dec 31, 2017 | $1.05M | – |
| Q3 FY2017 | Sep 30, 2017 | $684.00K | +34.9% |
| Q2 FY2017 | Jun 30, 2017 | $2.82M | – |
| Q1 FY2017 | Mar 31, 2017 | -$2.03M | – |
| Q4 FY2016 | Dec 31, 2016 | -$270.00K | – |
| Q3 FY2016 | Sep 30, 2016 | $507.00K | – |
| Q2 FY2016 | Jun 30, 2016 | -$112.00K | – |
See a number that looks wrong?